Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Indrayani BiotechBOM:526445 +2.95%51 Days Inventory is 151.08 as of Dec. 2025, which is 135% above its 10-year median of 64.16. GuruFocus rates BOM:526445 with a GF Score™ of 51/100 and a GF Value™ of ₹41.27 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 674 Business Services companies, Indrayani Biotech ranks worse than 85.31% on this metric.
The historical rank and industry rank for Indrayani Biotech's Days Inventory or its related term are showing as below:
BOM:526445'
s Days Inventory Range Over the Past 10 Years
Min: 11.66 Med: 64.16 Max: 184.53
Current: 139.9
During the past 13 years, Indrayani Biotech's highest Days Inventory was 184.53. The lowest was 11.66. And the median was 64.16.
BOM:526445's Days Inventory is ranked worse than 85.31% of 674
companies
in the Business Services industry
Industry Median: 25.26
vs BOM:526445: 139.90
Indrayani Biotech's Days Inventory
declined
from Dec. 2024 (367.02) to Dec. 2025 (151.08).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Indrayani Biotech's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.60.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Indrayani Biotech's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 1.23.
Indrayani Biotech (BOM:526445) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Indrayani Biotech's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Indrayani Biotech's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Indrayani Biotech Days Inventory Related Terms
Indrayani Biotech Days Inventory Historical Data
* Premium members only.
The historical data trend for Indrayani Biotech's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:526445 vs CTAS, CPRT, ULS: Days Inventory Comparison
For the Specialty Business Services subindustry, Indrayani Biotech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indrayani Biotech Days Inventory vs Business Services Industry
For the Business Services industry and Industrials sector, Indrayani Biotech's Days Inventory distribution charts can be found below:
* The bar in red indicates where Indrayani Biotech's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indrayani Biotech (BOM:526445) has a Days Inventory of 151.08 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Indrayani Biotech and its competitors. This is 135% above median its historical median of 64.16. Over the past decade, Indrayani Biotech's Days Inventory has ranged from 11.66 to 184.53. According to the industry distribution chart, Indrayani Biotech ranks #575 out of 674 companies in the Business Services industry, placing it in the top 85.3%.
Is Indrayani Biotech's Days Inventory too high?
Indrayani Biotech's current Days Inventory of 151.08 is 135% above median its 10-year median of 64.16. Over the past 10 years, this metric has ranged from a low of 11.66 to a high of 184.53. The Business Services industry median Days Inventory is 25.26. Indrayani Biotech's value of 151.08 is 498.1% above this industry median. Based on the distribution chart, Indrayani Biotech ranks #575 out of 674 companies in the Business Services industry, which is in the bottom quartile relative to peers. Overall, Indrayani Biotech has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indrayani Biotech's Days Inventory compare to CTAS and CPRT?
According to the Business Services industry distribution chart, Indrayani Biotech ranks #575 out of 674 companies for Days Inventory. This places Indrayani Biotech in the lower half of its industry. The industry median Days Inventory is 25.26. Indrayani Biotech's value of 151.08 is 498.1% above this benchmark. Historically, Indrayani Biotech's own Days Inventory has ranged from 11.66 to 184.53 over the past decade. While the company's 10-year median is 64.16 vs. the industry median of 25.26, Indrayani Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Business Services company?
The median Days Inventory among Business Services companies is 25.26, based on 674 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indrayani Biotech's current Days Inventory of 151.08 is 498.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Indrayani Biotech and its competitors. For the Business Services industry, the median Days Inventory is 25.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indrayani Biotech's current Days Inventory is 151.08, which is 135% above median its own 10-year median of 64.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indrayani Biotech stock overvalued right now?
Based on GuruFocus' analysis, Indrayani Biotech (BOM:526445) is currently considered Possible Value Trap. The stock's GF Value™ is ₹41.27, compared to a current price of ₹8.02 — trading 80.6% below its estimated fair value. The current Days Inventory is 151.08, which is 135% above median its 10-year median of 64.16 and 498.1% above the Business Services industry median of 25.26. Indrayani Biotech's overall GF Score™ is 51/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Indrayani Biotech (BOM:526445), the current Days Inventory is 151.08 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indrayani Biotech (BOM:526445) Overvalued in 2026?
Based on GuruFocus' analysis, Indrayani Biotech stock appears to be undervalued.
The current stock price of ₹8.02 is trading 80.6% below its estimated GF Value™ of ₹41.27.
GuruFocus considers Indrayani Biotech to be Possible Value Trap.
Key valuation signals for BOM:526445:
Days Inventory: 151.08 (135% above median its 10-year median of 64.16)
GF Value™: ₹41.27 vs. price of ₹8.02 (80.6% below fair value)
Industry Position: 498.1% above the Business Services median (#575 of 674)
No single metric tells the full story. See the BOM:526445 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indrayani Biotech Ltd operates in the Tri-segment i.e. Foods & Hospitality, Engineering and Healthcare divisions. The company generates its revenue from the sale of food, beverages, and other items; the Sale of Engineering products & Others. The majority of its revenue is generated from the sale of food, beverages, and other items.
51GF Score
Get the complete analysis for BOM:526445
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:526445 has been successfully added to your 
